The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the BSRBR-RA

Annals of the Rheumatic Diseases

Volumn 73, Issue 1, 2014, Pages 252-255

  Závada, Jakub ^a,b   Lunt, Mark ^a   Davies, Rebecca ^a   Low, Audrey S L ^a   Mercer, Louise K ^a   Galloway, James B ^a   Watson, Kath D ^a   Symmons, Deborah P ^a   Hyrich, Kimme L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT RESPONSE;

ANTI-TNF; CORTICOSTEROIDS; DMARDS (SYNTHETIC); NSAIDS; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTESTINAL PERFORATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; STOMACH DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84889641475     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-203102     Document Type: Article

References (19)

1. Ebert EC, Hagspiel KD. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Dig Dis Sci 2011;56:295-302.
2. Lanas A, Sopeña F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am 2009;38:333-52.
3. Wollheim FA. Acute and long term complications of corticosteroid pulse therapy. Scand J Rheumatol 1984;13(Suppl 54):27-32. (Pubitemid 14048867)
4. Weiner HL, Rezai AL, Cooper PR. Sigmoid diverticular per foration in neurosurgical patients receiving high-dose corticosteroids. Neurosurgery 1993;33:40-3. (Pubitemid 23204810)
5. Arsura EL. Corticosteroid-associated perforation of colonic diverticula. Arch Intern Med 1990;150:1337-8. (Pubitemid 20188472)
6. Remine SG, McParth DC. Bowel perforation in steroid treated patients. Ann Surg 1980;192:581-6.
7. Van Vollenhoven RF, Keystone EC, Furie R, et al. Gastrointestinal safety in patients with rheumatoid arthritis treated with tocilizumab: data from Roche clinical trials [abstract]. Arthritis Rheum 2009;60 Suppl:S602.
8. Koike R, Harigai M, Atsumi T, et al. Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheumatol 2009;19:351-7.
9. Gout T, Ostör AJ, Nisar MK. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. Clin Rheumatol 2011;30:1471-4.
10. SAFETY UPDATE ON TNF-α ANTAGONISTS: Infliximab and Etanercept. http://www.fda.gov/ohrms/dockets/ac/01/briefing/3779b2-01-cber-safety%20- revision2.pdf
11. Five-Year Data Demonstrate Initial Use of Abbott's HUMIRA® (adalimumab) Plus Methotrexate May Prevent Further Joint Damage in Early Rheumatoid Arthritis Patients. http://www.abbott.com/global/url/pressRelease/en- US/60.5:5/Press-Release-0737.htm
12. Corsi F, Previde P, Colombo F, et al. Two cases of intestinal perforation in patients on anti-rheumatic treatment with etanercept. Clin Exp Rheumatol 2006;24:113.
13. Takeuchi T, Tatsuki Y, Nogami Y, et al. Post marketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2007;67:189-94.
14. Koike T, Harigai M, Inokuma S, et al. Safety outcomes from a large Japanese post-marketing surveillance for etanercept. Arthritis Rheum 2007;56:S182.
15. Ruppert M, De Clerck L, van Offel J, et al. Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment. Acta Chir Belg 2006;106:225-7. (Pubitemid 43709771)
16. Gopalswamy S, Dindyal S, Arumugam P. A rare cause of Ischemic colitis and review of literature. Internet J Gastroenterol 2010;9. http://www.ispub.com/ journal/the-internet-journal-of-gastroenterology/volume-9-number-1/ a-rare-cause-of-ischemic-colitis-and-review-of-literature.html#sthash.uUFN5LlS. dpbs
17. Curtis JR, Xie F, Chen L, et al. The incidence of gastrointestinal perforations among rheumatoid arthritis patients. Arthritis Rheum 2011;63:346-51.
18. Curtis JR, Lanas A, John A, et al. Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:1819-28.
19. Hyrich K L, Watson KD, Isenberg DA, et al. The British Society for Rheumatology Biologics Register: 6 years on. Rheumatology(Oxford) 2008;47:1441-3.